DK0966533T3 - Aktivitetsafhængig neurotrof faktor III (ADNF III). - Google Patents

Aktivitetsafhængig neurotrof faktor III (ADNF III).

Info

Publication number: DK0966533T3
Authority: DK; Denmark
Prior art keywords: iii; adnf iii; activity; adnf; neurotrophic factor
Prior art date: 1997-02-07

Application number

DK98907407T

Other languages

English (en)

Inventor

Douglas E Brenneman

Illana Gozes

Merav Bassan

Original Assignee

Us Gov Health & Human Serv

Univ Ramot

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-02-07

Filing date

1998-02-06

Publication date

2010-01-04

1998-02-06 Application filed by Us Gov Health & Human Serv, Univ Ramot filed Critical Us Gov Health & Human Serv

1998-02-06 Priority claimed from PCT/US1998/002485 external-priority patent/WO1998035042A1/en

2010-01-04 Application granted granted Critical

2010-01-04 Publication of DK0966533T3 publication Critical patent/DK0966533T3/da

Links

108010027834 activity-dependent neurotrophic factor Proteins 0.000 title abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 5
229920001184 polypeptide Polymers 0.000 abstract 4
102000004196 processed proteins & peptides Human genes 0.000 abstract 4
102100022385 Activity-dependent neuroprotector homeobox protein Human genes 0.000 abstract 2
101710170468 Activity-dependent neuroprotector homeobox protein Proteins 0.000 abstract 2
208000024827 Alzheimer disease Diseases 0.000 abstract 1
101710091045 Envelope protein Proteins 0.000 abstract 1
HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 1
HOKKHZGPKSLGJE-UHFFFAOYSA-N N-methyl-D-aspartic acid Natural products CNC(C(O)=O)CC(O)=O HOKKHZGPKSLGJE-UHFFFAOYSA-N 0.000 abstract 1
101710188315 Protein X Proteins 0.000 abstract 1
102100021696 Syncytin-1 Human genes 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
230000030833 cell death Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000003492 excitotoxic effect Effects 0.000 abstract 1
231100000063 excitotoxicity Toxicity 0.000 abstract 1
230000004770 neurodegeneration Effects 0.000 abstract 1
230000004776 neurological deficiency Effects 0.000 abstract 1
150000007523 nucleic acids Chemical group 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
CFMYXEVWODSLAX-QOZOJKKESA-N tetrodotoxin Chemical compound O([C@@]([C@H]1O)(O)O[C@H]2[C@@]3(O)CO)[C@H]3[C@@H](O)[C@]11[C@H]2[C@@H](O)N=C(N)N1 CFMYXEVWODSLAX-QOZOJKKESA-N 0.000 abstract 1
229950010357 tetrodotoxin Drugs 0.000 abstract 1
CFMYXEVWODSLAX-UHFFFAOYSA-N tetrodotoxin Natural products C12C(O)NC(=N)NC2(C2O)C(O)C3C(CO)(O)C1OC2(O)O3 CFMYXEVWODSLAX-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Toxicology (AREA)
Psychiatry (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hospice & Palliative Care (AREA)
Zoology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Compounds Of Unknown Constitution (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Lock And Its Accessories (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)

DK98907407T 1997-02-07 1998-02-06 Aktivitetsafhængig neurotrof faktor III (ADNF III). DK0966533T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3740497P	1997-02-07	1997-02-07
PCT/US1998/002485 WO1998035042A1 (en)	1997-02-07	1998-02-06	Activity dependent neurotrophic factor iii (adnf iii)

Publications (1)

Publication Number	Publication Date
DK0966533T3 true DK0966533T3 (da)	2010-01-04

Family

ID=21894162

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98907407T DK0966533T3 (da)	1997-02-07	1998-02-06	Aktivitetsafhængig neurotrof faktor III (ADNF III).

Country Status (9)

Country	Link
EP (2)	EP2172478A3 (da)
JP (1)	JP4649602B2 (da)
AT (1)	ATE443141T1 (da)
AU (1)	AU737406B2 (da)
CA (1)	CA2279231C (da)
DE (1)	DE69841160D1 (da)
DK (1)	DK0966533T3 (da)
ES (1)	ES2331595T3 (da)
PT (1)	PT966533E (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4878551B2 (ja)	2004-04-08	2012-02-15	貞和相磯	運動ニューロン疾患治療薬
JP5174653B2 (ja) *	2005-03-23	2013-04-03	ラモトアトテルーアビブユニバーシティーリミテッド	末梢神経毒症状を処置するためのａｄｎｆポリペプチドの使用
US8956859B1 (en)	2010-08-13	2015-02-17	Aviex Technologies Llc	Compositions and methods for determining successful immunization by one or more vaccines
CN111201030B (zh)	2017-07-25	2024-11-01	真和制药有限公司	通过阻断tim-3和其配体的相互作用治疗癌症
KR20210124308A (ko)	2019-01-30	2021-10-14	트루바인딩 아이엔씨.	항-gal3 항체 및 이의 용도
MX2022014786A (es)	2020-05-26	2023-01-16	Truebinding Inc	Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3.

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL154598B (nl)	1970-11-10	1977-09-15	Organon Nv	Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en)	1971-05-14	1974-06-18	Syva Corp	Enzyme amplification assay
US3740497A (en)	1971-06-29	1973-06-19	G Daniell	Artificial line bridge subscriber dial long line equipment tester
US3939350A (en)	1974-04-29	1976-02-17	Board Of Trustees Of The Leland Stanford Junior University	Fluorescent immunoassay employing total reflection for activation
US3996345A (en)	1974-08-12	1976-12-07	Syva Company	Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en)	1978-04-05	1981-07-07	Syva Company	Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en)	1978-11-24	1981-06-23	Syva Company	Macromolecular environment control in specific receptor assays
US4254082A (en)	1978-06-12	1981-03-03	Miles Laboratories, Inc.	Specific binding-adsorbent assay test means
US4391904A (en)	1979-12-26	1983-07-05	Syva Company	Test strip kits in immunoassays and compositions therein
US4376110A (en)	1980-08-04	1983-03-08	Hybritech, Incorporated	Immunometric assays using monoclonal antibodies
US4366241A (en)	1980-08-07	1982-12-28	Syva Company	Concentrating zone method in heterogeneous immunoassays
US4517288A (en)	1981-01-23	1985-05-14	American Hospital Supply Corp.	Solid phase system for ligand assay
US4722848A (en)	1982-12-08	1988-02-02	Health Research, Incorporated	Method for immunizing animals with synthetically modified vaccinia virus
CH652145A5 (de)	1982-01-22	1985-10-31	Sandoz Ag	Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
JPS58215453A (ja)	1982-06-09	1983-12-14	Toray Silicone Co Ltd	室温硬化後塗装可能なオルガノポリシロキサン組成物
US4716111A (en)	1982-08-11	1987-12-29	Trustees Of Boston University	Process for producing human antibodies
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
US4634666A (en)	1984-01-06	1987-01-06	The Board Of Trustees Of The Leland Stanford Junior University	Human-murine hybridoma fusion partner
US4683202A (en)	1985-03-28	1987-07-28	Cetus Corporation	Process for amplifying nucleic acid sequences
US5169939A (en)	1985-05-21	1992-12-08	Massachusetts Institute Of Technology & Pres. & Fellows Of Harvard College	Chimeric antibodies
CA1291031C (en)	1985-12-23	1991-10-22	Nikolaas C.J. De Jaeger	Method for the detection of specific binding agents and their correspondingbindable substances
IL84285A (en)	1986-10-27	1993-03-15	Int Genetic Engineering	Chimeric antibody with specificity to human tumor antigen
IL85035A0 (en)	1987-01-08	1988-06-30	Int Genetic Eng	Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5001065A (en)	1987-05-27	1991-03-19	Cetus Corporation	Human cell line and triomas, antibodies, and transformants derived therefrom
US5204244A (en)	1987-10-27	1993-04-20	Oncogen	Production of chimeric antibodies by homologous recombination
US5202238A (en)	1987-10-27	1993-04-13	Oncogen	Production of chimeric antibodies by homologous recombination
US5231026A (en)	1987-12-31	1993-07-27	Tanox Biosystems, Inc.	DNA encoding murine-human chimeric antibodies specific for antigenic epitopes of IgE present on the extracellular segment of the membrane domain of membrane-bound IgE
US4975369A (en)	1988-04-21	1990-12-04	Eli Lilly And Company	Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen
US5292867A (en)	1988-11-16	1994-03-08	Tanox Biosystems, Inc.	Chimeric monoclonal antibodies which bind to the extracellular segment of the membrane-bound domain of a human membrane-bound immunoglobulin
IL94872A (en)	1989-06-30	1995-03-30	Oncogen	Monoclonal or chimeric antibodies reactive with human carcinomas, recombinant proteins comprising their antigen binding region, pharmaceutical compositions and kits comprising said antibodies and methods for imaging human carcinoma using same
US5081235A (en)	1989-07-26	1992-01-14	City Of Hope	Chimeric anti-cea antibody
US5075431A (en)	1989-07-26	1991-12-24	City Of Hope	Chimeric anti-CEA antibody
US6174862B1 (en) *	1991-04-22	2001-01-16	Ramot University Authority For Applied Research And Industrial Development, Ltd.	Neurotrophic peptides of activity dependent neurotrophic factor
US5767240A (en) *	1991-04-22	1998-06-16	The United States Of America As Represented By The Department Of Health And Human Services	Activity-dependent neurotrophic factor
GB9125979D0 (en)	1991-12-06	1992-02-05	Wellcome Found	Antibody
US5472693A (en)	1993-02-16	1995-12-05	The Dow Chemical Company	Family of anti-carcinoembryonic antigen chimeric antibodies
US5506132A (en)	1993-07-28	1996-04-09	Sandoz Pharmaceuticals Corporation	Human antibodies against varicella-zoster virus
US5426039A (en)	1993-09-08	1995-06-20	Bio-Rad Laboratories, Inc.	Direct molecular cloning of primer extended DNA containing an alkane diol

1998
- 1998-02-06 EP EP09170287A patent/EP2172478A3/en not_active Withdrawn
- 1998-02-06 PT PT98907407T patent/PT966533E/pt unknown
- 1998-02-06 DK DK98907407T patent/DK0966533T3/da active
- 1998-02-06 ES ES98907407T patent/ES2331595T3/es not_active Expired - Lifetime
- 1998-02-06 AT AT98907407T patent/ATE443141T1/de active
- 1998-02-06 JP JP53498298A patent/JP4649602B2/ja not_active Expired - Fee Related
- 1998-02-06 DE DE69841160T patent/DE69841160D1/de not_active Expired - Lifetime
- 1998-02-06 CA CA2279231A patent/CA2279231C/en not_active Expired - Fee Related
- 1998-02-06 AU AU63222/98A patent/AU737406B2/en not_active Ceased
- 1998-02-06 EP EP98907407A patent/EP0966533B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ATE443141T1 (de)	2009-10-15
DE69841160D1 (de)	2009-10-29
JP2001522228A (ja)	2001-11-13
AU6322298A (en)	1998-08-26
EP2172478A3 (en)	2010-07-28
CA2279231C (en)	2013-11-26
CA2279231A1 (en)	1998-08-13
WO1998035042A2 (en)	1998-08-13
WO1998035042A8 (en)	2006-11-09
EP0966533A1 (en)	1999-12-29
PT966533E (pt)	2010-01-26
AU737406B2 (en)	2001-08-16
EP2172478A2 (en)	2010-04-07
JP4649602B2 (ja)	2011-03-16
EP0966533B1 (en)	2009-09-16
ES2331595T3 (es)	2010-01-08

Publication	Publication Date	Title
WO2000027875A3 (en)	2000-07-27	Activity dependent neurotrophic factor iii (adnf iii)
EP1439230A3 (en)	2004-09-22	Human transmembrane protein TMP-2 gene
WO2001079444A3 (en)	2002-05-23	Albumin fusion proteins
IL197339A0 (en)	2011-07-31	Recombinant uricase protein
WO1995021919A3 (en)	1995-12-07	Protein having tpo activity
EP0769554A3 (en)	1997-05-28	Human CNP gene and precursor protein
SI0917571T1 (en)	2005-06-30	Agouti-related gene
EP0258411A4 (en)	1988-08-23	DNA ENCODING STREPTAVIDINE, SPREPTAVIDINE THUS PRODUCED, FUSED POLYPEPTIDES COMPRISING AMINO ACID SEQUENCES PRESENT IN STREPTAVIDINE AND THEIR USES.
WO2003030821A3 (en)	2003-12-11	Albumin fusion proteins
WO1998014596A3 (en)	1998-08-20	Disease associated protein tyrosine phosphatases
DE60142239D1 (de)	2010-07-08	DEN PHOSPHORSÄURE-METABOLISMUS, DEN KALZIUM-METABOLISMUS, VERKALKUNG UND DEN VITAMIN D-METABOLISMUS KONTROLLIERENDE POLYPEPTIDE SOWIE FüR DIESE KODIERENDE DNA-MOLEKÜLE
WO2000015659A3 (en)	2000-06-08	Stomach polypeptide zsig28
CA2336261A1 (en)	1999-12-09	Cyclin e2 genes and proteins
WO1993017031A3 (en)	1993-12-23	Nucleic acids encoding dystrophin-associated proteins
ATE443141T1 (de)	2009-10-15	Aktivitätsabhänginger neurotropischer faktor iii(adnf iii)
ATE403726T1 (de)	2008-08-15	Cytokin-proteinfamilie
AU2001232275A1 (en)	2001-08-20	Novel collagen-like protein clac, precursor thereof and genes encoding the same
DK1108786T3 (da)	2007-04-16	Hidtil ukendt kollektin
AU2001238064A1 (en)	2001-08-20	18477, a human protein kinase and uses therefor
WO2000037613A3 (en)	2000-11-16	Human akt-3
EP1023906A4 (en)	2005-03-02	POTENTIATOR FOR ANTI-TUMOR ANTIBODY LYMPHOID
ATE353913T1 (de)	2007-03-15	Neue collectine
WO2000044898A3 (en)	2000-12-28	Novel agouti and agouti-related peptide analogs
WO2001000662A3 (en)	2001-05-17	The use of human fgh-8 polypeptides as neurotrophic agents
WO2002008424A1 (fr)	2002-01-31	Genes abca2 humain et de rat